Viewing Study NCT01004003

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 7:37 PM

Ignite Modification Date: 2025-12-25 @ 5:18 PM

Study NCT ID: NCT01004003

Status: COMPLETED

Last Update Posted: 2017-10-26

First Post: 2009-10-12

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Sponsor: Boehringer Ingelheim

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module